Genmab (GMAB DC) sees FY profit between USD 3.81-4.11bln, sees FY EBIT between USD 0.9-1.4bln; sees FY operating expenses between USD 2.71-2.91bln

Genmab's projected FY profit and EBIT fall within a wide range, indicating potential volatility in expectations.

Newsquawk StaffPublished On the live feed at 3 more headlines followed before this page went public
Newsquawk headlinesUTC

A senior White House official says "Progress has been made in the talks with Iran, but there are still many details to be discussed....", Axios' Ravid reports

Ford (F) to follow Tesla (TSLA) Cybertruck with electrical tech in new EV pickup

Genmab (GMAB DC) sees FY profit between USD 3.81-4.11bln, sees FY EBIT between USD 0.9-1.4bln; sees FY operating expenses between USD 2.71-2.91bln

US is to sell USD 69bln of 17-week bills on February 18th, and USD 95bln of 8-week bills and USD 105bln of 4-week bills on February 19th; all to settle on February 24th

Newsquawk Daily Economic Releases - 18th February 2026

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

The guidance for operating expenses adds further context, suggesting margins may be squeezed, which could impact investor sentiment and stock pricing. This outlook will be crucial to monitor for sector peers and market reactions as it highlights both growth potential and cost pressures.

Related headlines

The whole workspace, free to try.

Try it free